PL445383A1 - Zastosowanie 8-glukozydu emodyny w leczeniu raka piersi - Google Patents

Zastosowanie 8-glukozydu emodyny w leczeniu raka piersi

Info

Publication number
PL445383A1
PL445383A1 PL445383A PL44538323A PL445383A1 PL 445383 A1 PL445383 A1 PL 445383A1 PL 445383 A PL445383 A PL 445383A PL 44538323 A PL44538323 A PL 44538323A PL 445383 A1 PL445383 A1 PL 445383A1
Authority
PL
Poland
Prior art keywords
emodin
treatment
breast cancer
glucoside
anticancer activity
Prior art date
Application number
PL445383A
Other languages
English (en)
Other versions
PL247645B1 (pl
Inventor
Anna Wawruszak
Wirginia Kukuła-Koch
Estera Okoń
Andrzej Stepulak
Original Assignee
Uniwersytet Medyczny W Lublinie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL445383A priority Critical patent/PL247645B1/pl
Publication of PL445383A1 publication Critical patent/PL445383A1/pl
Publication of PL247645B1 publication Critical patent/PL247645B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Celem rozwiązania według wynalazku jest zastosowanie glikozylowanej formy emodyny o działaniu przeciwnowotworowym jako związku z grupy pochodnych antracenu w leczeniu nowotworów piersi. Istotą rozwiązania według wynalazku jest 8-glukozyd emodyny do zastosowania w leczeniu nowotworów piersi. Wynalazek daje możliwość wykorzystania przeciwnowotworowej aktywności glukozydu emodyny i stosowania go jako potencjalnego leku lub składnika preparatów farmaceutycznych w przemyśle farmaceutycznym do terapii chorych z nowotworami piersi.
PL445383A 2023-06-28 2023-06-28 Zastosowanie 8-glukozydu emodyny w leczeniu raka piersi PL247645B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445383A PL247645B1 (pl) 2023-06-28 2023-06-28 Zastosowanie 8-glukozydu emodyny w leczeniu raka piersi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445383A PL247645B1 (pl) 2023-06-28 2023-06-28 Zastosowanie 8-glukozydu emodyny w leczeniu raka piersi

Publications (2)

Publication Number Publication Date
PL445383A1 true PL445383A1 (pl) 2024-12-30
PL247645B1 PL247645B1 (pl) 2025-08-18

Family

ID=96736220

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445383A PL247645B1 (pl) 2023-06-28 2023-06-28 Zastosowanie 8-glukozydu emodyny w leczeniu raka piersi

Country Status (1)

Country Link
PL (1) PL247645B1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191140B (zh) * 2013-03-19 2015-04-01 孙震晓 大黄素-8-O-β-D-葡萄糖苷的抗肿瘤活性及其新用途

Also Published As

Publication number Publication date
PL247645B1 (pl) 2025-08-18

Similar Documents

Publication Publication Date Title
SA522441701B1 (ar) مشتقات كينوكسالين كعقاقير مضادة للسرطان
AR132802A1 (es) 2-amino-3-cianotiofenos con anillos espirocíclicos y derivados para el tratamiento del cáncer
FI3788047T3 (fi) Fgft-estäjän kiinteitä muotoja ja menetelmiä niiden valmistamiseksi
MX2024005304A (es) Derivado del acido fenilpropionico sustituido y uso del mismo.
BR112017017448A2 (pt) métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho
MX2020000265A (es) Composiciones para la administración parenteral de agentes terapéuticos.
BR112015011497A2 (pt) composto, formulação farmacêutica, produto de combinação, e, método de tratamento de uma doença
MX2023003678A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2022005985A (es) Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo.
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
MX2023005913A (es) Derivados de bencenosulfonamida y usos de los mismos.
EP3489252A4 (en) PEPTIDE WITH ANTI-CANCER EFFECT AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER, FUNCTIONAL FOOD COMPOSITION AND FUNCTIONAL COSMETIC COMPOSITION THEREFORE AS AN ACTIVE SUBSTANCE
BR112023022647A2 (pt) Derivado de 7-nitro-8-hidroxiquinolina, método de preparação do mesmo e uso médico do mesmo
CL2023002698A1 (es) Inhibidores de integrina alpha v beta 6 y alpha v beta 1 y sus usos
MX2019013683A (es) Una combinacion farmaceutica para el tratamiento de un cancer.
PL445382A1 (pl) Zastosowanie 8-glukozydu emodyny w leczeniu nowotworów układu nerwowego
CL2023003209A1 (es) Composición farmacéutica de pembrolizumab y su uso
ECSP22092205A (es) Composición farmacéutica acuosa de levilimab y su uso
JOP20190287B1 (ar) توليفة من مثبط mcl-1 وعلاج رعاية قياسي لسرطانات الدم، استخدامتها وتركيبات صيدلانية منها
EA201992149A1 (ru) Комбинация активных ингредиентов, содержащие ее композиции и их применение в лечении саркопении
PL447378A1 (pl) Zastosowanie lepidylin w leczeniu nowotworu układu nerwowego.
CO2026001588A2 (es) Compuestos de fluoroalcoxialquileno-dihidroimidazo[5,1-d]tetrazinona y compuestos relacionados y su uso en el tratamiento de afecciones médicas
EA202090246A1 (ru) Композиции для парентерального введения терапевтических средств
MX2024003271A (es) Formas farmaceuticas multiparticulas que comprenden deutetrabenazina.
MX2024007450A (es) Combinaciones farmaceuticas para utilizarse en el tratamiento de enfermedades neoplasicas.